Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Cancer Cytopathology|April 9, 2024
Atypia of undetermined significance and ThyroSeq v3-positive call rates as quality control metrics for cytology laboratory performanceOdille Mejia-Mejia, Andres Bravo-Gonzalez, Monica Sanchez-Avila, et al.
American Journal of Clinical Pathology|September 11, 2021
Global Cytopathology-Hematopathology Practice TrendsSara L Zadeh, Ronald Balassanian, Matthew C Cheung, et al.
Plos One|January 26, 2023
Starting from scratch: Step-by-step development of diagnostic tests for SARS-CoV-2 detection by RT-LAMPDiana Angélica Tapia-Sidas, Brenda Yazmín Vargas-Hernández, José Abrahán Ramírez-Pool, et al.
BMC Cancer|February 2, 2020
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutationsRoberto Ruiz-Cordero, Junsheng Ma, Abha Khanna, et al.
Science Bulletin|June 24, 2026
Global fits and the search for new physics: past, present and future, Peter Athron, Csaba Balázs, et al.
Frontiers in Oncology|June 21, 2024
Performance of <i>MYC</i>, <i>BCL2</i>, and <i>BCL6</i> break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium studyJoshua R Menke, Umut Aypar, Charles D Bangs, et al.
The Journal of Molecular Diagnostics : JMD|December 23, 2018
Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample CollectionKeyur P Patel, Roberto Ruiz-Cordero, Wei Chen, et al.
The American Journal of Surgical Pathology|December 20, 2022
Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative StudyAshley K Volaric, Oscar Lin, Ronald Balassanian, et al.
Journal of the American Society of Cytopathology|August 3, 2025
Optimizing cytology and small biopsy specimen processing for ancillary studies: recommendations from the American Society of Cytopathology taskforceSinchita Roy-Chowdhuri, Christine N Booth, Jonas J Heymann, et al.
European Urology Oncology|November 5, 2025
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade SamplesRoberto Ruiz-Cordero, Qi Wang, Gayatri Kumar, et al.
Pageof 19